Syrs stock forecast

SYRS Stock - Syros Pharmaceuticals - Buy, Sell, or Hold SYRS Analysis Overview . What this means: Syros Pharmaceuticals (SYRS) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.

Nov 15, 2019 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) came out with its third-quarter results last week, and we wanted to see how the business is performing and what top analysts think of the company following this report.Revenues came in 28% better than analyst models expected, at US$558kwhile losses per share were US$0.47, in line with forecasts. Syros Pharmaceuticals Stock Quote: SYRS Stock News, Quotes ... Oct 31, 2019 · SYRS, Syros Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Syros Pharmaceuticals (NASDAQ:SYRS) Raised to “Hold” at ...

SYRS investment & stock information. Get the latest Syros Pharmaceuticals, Inc . SYRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Should you invest in Syros Pharmaceuticals (NasdaqGS:SYRS)? Earnings vs Market: SYRS is forecast to remain unprofitable over the next 3 years. SYRS, NasdaqGS (Nasdaq Global Select), Yes, Common Stock, US, USD, Jun 2016. SYRS investment & stock information. Get the latest Syros Pharmaceuticals, Inc . SYRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Provide final forecasts with revisions based on feedback. - Provide Changing land use and loss of stock (demolitions) •em;• forecast.id economy.id ,__ ___ !! _ _ Malvern - Kooyong (EW) - Summary of forecasts. Change in pop. (Syrs). potential, the relation between the SYRS and the SPEI explaining up to 62% of the low-yield variability. characterize, monitor, forecast, and manage drought. Equities analysts forecast that Syros Pharmaceuticals Inc (NASDAQ:SYRS) will post Syros Pharmaceuticals Closes $40 Million Preferred Stock Financing.

Dec 18, 2019 · What is the Forecast Price for Syros Pharmaceuticals Inc (SYRS) Stock? Wednesday, December 18, 2019 2:38 PM | InvestorsObserver Analysts . Analysts who follow Syros Pharmaceuticals Inc on average expect it to climb 149.08% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.

Nov 15, 2019 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) came out with its third-quarter results last week, and we wanted to see how the business is performing and what top analysts think of the company following this report.Revenues came in 28% better than analyst models expected, at US$558kwhile losses per share were US$0.47, in line with forecasts. Syros Pharmaceuticals Stock Quote: SYRS Stock News, Quotes ... Oct 31, 2019 · SYRS, Syros Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

Forecast Cash Runway: SYRS has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of -22.8% each year. Next Steps Explore more healthy companies in the Pharmaceuticals & Biotech industry.

View the real-time SYRS price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Syros against related stocks people have also bought like ACB, VKTX, INO, and F. 1,328 people own Syros on Robinhood on April 3, 2020. Syros Pharmaceuticals Inc. Stock (SYRS): Technical ...

Syros Pharmaceuticals Stock Quote: SYRS Stock News, Quotes ...

Get Roku Inc (ROKU:NASDAQ) real-time stock quotes, news and financial information from CNBC. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. SYRS Price Target | Syros Pharmaceuticals Stock Forecast ... See Syros Pharmaceuticals price target based on 4 analysts offering 12 month price targets for Syros Pharmaceuticals in the last 3 months. The average price target is $9.33 with a high forecast of $11.00 and a low forecast of $8.00. The average price target represents a 72.46% increase from the last price of … Syros Pharmaceuticals (NasdaqGS:SYRS) - Share price, News ...

SYRS Stock Quote of Syros Pharmaceuticals Dec 18, 2019 · Check out our SYRS stock analysis, current SYRS quote, charts, and historical prices for Syros Pharmaceuticals stock. SYRS Stock Predictions, Articles, and Syros Pharmaceuticals News. SYRS Syros Pharmaceuticals — Stock Price and Discussion ...